NexImmune (NEXI) Competitors $0.24 +0.00 (+1.21%) (As of 02:14 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NEXI vs. CFRX, SQZ, TFFP, ASLN, ZVSA, ADXS, QLGN, NMTR, EVFM, and PTEIQShould you be buying NexImmune stock or one of its competitors? The main competitors of NexImmune include ContraFect (CFRX), SQZ Biotechnologies (SQZ), TFF Pharmaceuticals (TFFP), ASLAN Pharmaceuticals (ASLN), ZyVersa Therapeutics (ZVSA), Ayala Pharmaceuticals (ADXS), Qualigen Therapeutics (QLGN), 9 Meters Biopharma (NMTR), Evofem Biosciences (EVFM), and PolarityTE (PTEIQ). These companies are all part of the "medical" sector. NexImmune vs. ContraFect SQZ Biotechnologies TFF Pharmaceuticals ASLAN Pharmaceuticals ZyVersa Therapeutics Ayala Pharmaceuticals Qualigen Therapeutics 9 Meters Biopharma Evofem Biosciences PolarityTE NexImmune (NASDAQ:NEXI) and ContraFect (NASDAQ:CFRX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Which has higher valuation and earnings, NEXI or CFRX? NexImmune is trading at a lower price-to-earnings ratio than ContraFect, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexImmuneN/AN/A-$32.34M-$18.54-0.01ContraFectN/AN/A-$65.15M-$19.270.00 Which has more risk and volatility, NEXI or CFRX? NexImmune has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, ContraFect has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Is NEXI or CFRX more profitable? ContraFect's return on equity of 0.00% beat NexImmune's return on equity.Company Net Margins Return on Equity Return on Assets NexImmuneN/A -534.32% -213.72% ContraFect N/A N/A -138.70% Does the media prefer NEXI or CFRX? In the previous week, NexImmune had 1 more articles in the media than ContraFect. MarketBeat recorded 1 mentions for NexImmune and 0 mentions for ContraFect. NexImmune's average media sentiment score of 0.00 equaled ContraFect'saverage media sentiment score. Company Overall Sentiment NexImmune Neutral ContraFect Neutral Does the MarketBeat Community favor NEXI or CFRX? ContraFect received 209 more outperform votes than NexImmune when rated by MarketBeat users. However, 61.11% of users gave NexImmune an outperform vote while only 52.14% of users gave ContraFect an outperform vote. CompanyUnderperformOutperformNexImmuneOutperform Votes2261.11% Underperform Votes1438.89% ContraFectOutperform Votes23152.14% Underperform Votes21247.86% Do insiders & institutionals believe in NEXI or CFRX? 9.9% of NexImmune shares are owned by institutional investors. Comparatively, 7.9% of ContraFect shares are owned by institutional investors. 14.9% of NexImmune shares are owned by company insiders. Comparatively, 0.6% of ContraFect shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryNexImmune beats ContraFect on 7 of the 11 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEXI vs. The Competition Export to ExcelMetricNexImmunePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$338,000.00$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.015.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book0.0710.276.976.37Net Income-$32.34M$153.22M$118.73M$225.56M7 Day Performance-24.91%-1.19%-1.22%-0.02%1 Month Performance-3.39%-6.71%-3.07%2.04%1 Year Performance-88.15%32.39%32.52%28.00% NexImmune Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEXINexImmuneN/A$0.24+1.2%N/A-90.3%$338,000.00N/A-0.016News CoverageGap DownCFRXContraFectN/A$0.05-28.0%N/A-9.1%$535,000.00N/A0.0023Gap DownSQZSQZ BiotechnologiesN/A$0.02flatN/A+15.0%$678,000.00$18.16M-0.011,620TFFPTFF Pharmaceuticals1.6867 of 5 stars$0.37+0.5%$44.00+11,655.3%-94.5%$1.30M$730,000.000.0019Gap UpHigh Trading VolumeASLNASLAN Pharmaceuticals1.1723 of 5 stars$0.60flat$76.00+12,566.7%N/A$1.23M$12M-0.0330ZVSAZyVersa Therapeutics2.3628 of 5 stars$1.15flat$120.00+10,334.8%-95.9%$1.18MN/A0.002ADXSAyala PharmaceuticalsN/A$0.03-74.8%N/A-96.7%$1.15M$10,000.000.0020Analyst ForecastNews CoverageGap DownQLGNQualigen TherapeuticsN/A$4.41+14.0%N/A-89.1%$1.10M$4.98M0.0050News CoverageGap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220EVFMEvofem Biosciences0.8097 of 5 stars$0.01flatN/A-85.3%$1.03M$18.22M-0.02120Gap UpPTEIQPolarityTEN/A$0.13flatN/A+50.1%$923,000.00$810,000.00-0.0460Gap Down Related Companies and Tools Related Companies ContraFect Competitors SQZ Biotechnologies Competitors TFF Pharmaceuticals Competitors ASLAN Pharmaceuticals Competitors ZyVersa Therapeutics Competitors Ayala Pharmaceuticals Competitors Qualigen Therapeutics Competitors 9 Meters Biopharma Competitors Evofem Biosciences Competitors PolarityTE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NEXI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEXI Stock Alerts